Literature DB >> 32141825

Analysis of correlation between liver fat fraction and AST and ALT levels in overweight and obese children by using new magnetic resonance imaging technique.

Berhan Pirimoğlu1, Recep Sade1, Gökhan Polat1, Ali İşlek2, Mecit Kantarcı1.   

Abstract

BACKGROUND/AIMS: Proton density fat fraction (PDFF) magnetic resonance (MR) imaging can be a useful technique for volumetric measurements of liver fat. The purpose of our study was to evaluate the correlation between liver fat fraction (LFF) and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in children who are overweight and obese.
MATERIALS AND METHODS: Overall, 25 children, aged 9-17 years, were included. Patients with a body mass index (BMI) z-score between 85-95th percentile (12 of 25 patients) were assigned to the overweight group, and those with BMI z-score above 95th percentile (13 of 25 patients) were assigned to the obese group. The control group comprised 12 healthy children with BMI z-score below 85th percentile. Liver fat fraction measurements were performed on 3D volume measurement workstation by using PDFF magnetic resonance (MR) images. Spearman's correlation coefficients between liver fat fraction and AST and ALT levels were evaluated individually for overweight, obese, and control groups. Receiver operator characteristics (ROC) analysis was also performed.
RESULTS: In the overweight and obese groups, the liver proton density fat fraction and AST levels had a strong correlation (r=0.716, p<0.001). In addition, the LFF and ALT levels demonstrated a strong correlation (r=0.878, p<0.001). ROC analysis ascertained an optimal liver fat fraction threshold of 114 for predicting AST level (sensitivity=75%, specificity=89%). ROC analysis ascertained an optimal LFF threshold of 114 for predicting ALT level (sensitivity=80%, specificity=90%).
CONCLUSION: Our results indicate a strong correlation between LFF values and AST and ALT levels in children who are overweight and obese.

Entities:  

Year:  2020        PMID: 32141825      PMCID: PMC7062128          DOI: 10.5152/tjg.2020.18594

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  25 in total

Review 1.  Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy.

Authors:  Scott B Reeder; Irene Cruite; Gavin Hamilton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-09-16       Impact factor: 4.813

2.  Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase.

Authors:  Kristen J Nadeau; Georgeanna Klingensmith; Phillip Zeitler
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-07       Impact factor: 2.839

3.  Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease.

Authors:  N Y Yu; T Wolfson; M S Middleton; G Hamilton; A Gamst; J E Angeles; J B Schwimmer; C B Sirlin
Journal:  Clin Radiol       Date:  2017-01-05       Impact factor: 2.350

4.  Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.

Authors:  Tania S Burgert; Sara E Taksali; James Dziura; T Robin Goodman; Catherine W Yeckel; Xenophon Papademetris; R Todd Constable; Ram Weiss; William V Tamborlane; Mary Savoye; Aisha A Seyal; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2006-08-15       Impact factor: 5.958

5.  Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.

Authors:  M Graif; M Yanuka; M Baraz; A Blank; M Moshkovitz; A Kessler; T Gilat; J Weiss; E Walach; P Amazeen; C S Irving
Journal:  Invest Radiol       Date:  2000-05       Impact factor: 6.016

Review 6.  Insulin resistance: a metabolic pathway to chronic liver disease.

Authors:  Elisabetta Bugianesi; Arthur J McCullough; Giulio Marchesini
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

7.  Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome.

Authors:  Perry J Pickhardt; Young Jee; Stacy D O'Connor; Alejandro Muñoz del Rio
Journal:  AJR Am J Roentgenol       Date:  2012-05       Impact factor: 3.959

8.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

9.  Hepatic steatosis and severity-related factors in obese children.

Authors:  Jose Maria Navarro-Jarabo; Esther Ubiña-Aznar; Leopoldo Tapia-Ceballos; Carmen Ortiz-Cuevas; M Angeles Pérez-Aísa; Francisco Rivas-Ruiz; Raul J Andrade; Emilio Perea-Milla
Journal:  J Gastroenterol Hepatol       Date:  2013-09       Impact factor: 4.029

10.  Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study.

Authors:  Paula A Monteiro; Jorge Mota; Loreana S Silveira; Suziane U Cayres; Bárbara de Moura M Antunes; Romulo Araujo Fernandes; Ismael F Freitas
Journal:  BMC Res Notes       Date:  2013-03-09
View more
  2 in total

1.  ALT/AST as an Independent Risk Factor of Gestational Diabetes Mellitus Compared with TG/HDL-C.

Authors:  Shuoning Song; Yuemei Zhang; Xiaolin Qiao; Yanbei Duo; Jiyu Xu; Zhenyao Peng; Jing Zhang; Yan Chen; Xiaorui Nie; Qiujin Sun; Xianchun Yang; Ailing Wang; Zechun Lu; Wei Sun; Yong Fu; Yingyue Dong; Tao Yuan; Weigang Zhao
Journal:  Int J Gen Med       Date:  2022-01-05

2.  Vitamin D3 Protects Mice from Diquat-Induced Oxidative Stress through the NF-κB/Nrf2/HO-1 Signaling Pathway.

Authors:  Haiwen Zhang; Youming Liu; Xin Fang; Lihong Gu; Caiwei Luo; Lu Chen; Qian Wang
Journal:  Oxid Med Cell Longev       Date:  2021-11-16       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.